Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management purchased 10,481 shares of the firm’s stock in a transaction on Wednesday, February 18th. The stock was acquired at an average price of $2.29 per share, for a total transaction of $24,001.49. Following the completion of the transaction, the insider directly owned 669,598 shares of the company’s stock, valued at approximately $1,533,379.42. This trade represents a 1.59% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Thursday, February 19th, Glenbrook Capital Management purchased 34,613 shares of Senestech stock. The shares were acquired at an average price of $2.40 per share, for a total transaction of $83,071.20.
- On Tuesday, February 17th, Glenbrook Capital Management acquired 40,807 shares of Senestech stock. The shares were acquired at an average cost of $2.29 per share, with a total value of $93,448.03.
- On Friday, February 13th, Glenbrook Capital Management acquired 15,390 shares of Senestech stock. The stock was bought at an average price of $1.89 per share, with a total value of $29,087.10.
- On Thursday, February 12th, Glenbrook Capital Management bought 7,956 shares of Senestech stock. The stock was bought at an average cost of $1.72 per share, for a total transaction of $13,684.32.
- On Wednesday, February 11th, Glenbrook Capital Management bought 8,000 shares of Senestech stock. The shares were bought at an average price of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management purchased 2,884 shares of Senestech stock. The shares were bought at an average cost of $1.77 per share, with a total value of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management purchased 5,685 shares of Senestech stock. The stock was bought at an average price of $1.82 per share, with a total value of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management acquired 42,739 shares of Senestech stock. The stock was bought at an average cost of $1.98 per share, for a total transaction of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The shares were bought at an average cost of $1.87 per share, for a total transaction of $10,096.13.
Senestech Stock Performance
Shares of NASDAQ:SNES traded up $0.06 during mid-day trading on Thursday, reaching $2.40. 126,958 shares of the company traded hands, compared to its average volume of 69,302. The company’s 50 day moving average price is $2.13 and its 200-day moving average price is $3.34. The firm has a market cap of $12.53 million, a PE ratio of -0.66 and a beta of 0.21. Senestech, Inc. has a 52 week low of $1.30 and a 52 week high of $6.24. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73.
Analyst Ratings Changes
Get Our Latest Analysis on Senestech
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in Senestech in the 4th quarter worth approximately $32,000. Diversify Advisory Services LLC bought a new position in shares of Senestech during the fourth quarter worth $34,000. XTX Topco Ltd bought a new position in shares of Senestech during the fourth quarter worth $54,000. Geode Capital Management LLC purchased a new position in Senestech during the second quarter valued at $59,000. Finally, Essex Investment Management Co. LLC purchased a new position in Senestech during the third quarter valued at $115,000. 5.19% of the stock is owned by hedge funds and other institutional investors.
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Read More
- Five stocks we like better than Senestech
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
